Abernethy, D R <br/><br/>
Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonist.  [electronic resource] 

 -  The American journal of cardiology  Aug 1997 
 - 4C-11C p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(97)00564-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzimidazoles--chemistry<br/>Binding Sites<br/>Calcium Channel Blockers--chemistry<br/>Cardiovascular Diseases--drug therapy<br/>Controlled Clinical Trials as Topic<br/>Coronary Vessels--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Half-Life<br/>Heart Conduction System--drug effects<br/>Heart Rate--drug effects<br/>Hemodynamics--drug effects<br/>Humans<br/>In Vitro Techniques<br/>Mibefradil<br/>Muscle, Smooth--drug effects<br/>Renal Circulation--drug effects<br/>Tetrahydronaphthalenes--chemistry<br/>Vascular Resistance--drug effects